IMARC Group’s latest report, titled “3D Printing in Healthcare Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” finds that the global 3D printing in healthcare market size reached US$ 2.6 Billion in 2022. 3D printing, also known as additive manufacturing, refers to the process of making solid three-dimensional objects. It is commonly used in the healthcare sector to create new surgical cutting drill guides, prosthetics, and patient-specific replicas of bones, organs, and blood vessels. It facilitates the customization and personalization of medical products, drugs, and equipment and assists in producing living human cells or tissue in regenerative medicine and tissue engineering. It helps minimize operative risks involved during complex medical procedures, lowers the chances of infections, and reduces the duration of anesthesia exposure. It also aids in saving time, decreasing costs, and enabling faster and more effective delivery of medical services. As a result, 3D printing in healthcare has gained immense traction across the globe for manufacturing customized prosthetics, implants, and other wearable devices.
Global 3D Printing in Healthcare Market Trends:
The rising preferences for customized medical products and the surging popularity of precision medicine represent the primary factors driving the market growth. Besides this, the increasing incidences of chronic diseases, such as cancer and respiratory and cardiovascular disorders (CVDs), are other major growth-inducing factors. Additionally, there is a rise in the use of 3D printing in liver modeling and the development of tissue, bone, and medical implants. In line with this, the escalating demand for regenerative medicines, stem cell solutions, and cancer therapeutics has catalyzed market growth. Apart from this, the growing usage of technologically advanced products for patient monitoring and disease management to improve patient care quality and reduce the cost of care has augmented the demand for 3D printing in healthcare. Furthermore, the rising public and private funding to expand 3D printing manufacturing capabilities have propelled the market growth. Along with this, continual technological advancements in 3D printers and heavy investments in aggressive promotional activities and marketing campaigns by key players are contributing to market growth. Other factors, including the expanding geriatric population, increasing biomedical and pharmaceutical applications, easy availability of bioprinting tissues and organs, and ongoing research and development (R&D) activities, are also providing a positive thrust to the market growth. Looking forward, IMARC Group expects the market value to reach US$ 6.5 Billion by 2028, growing at a CAGR of 15.1% during 2023-2028.
- Based on the material, the market has been categorized into polymer, metals, ceramic, and organic.
- On the basis of technology, the market has been segregated into droplet deposition [fused filament fabrication (FFF) technology, low-temperature deposition manufacturing (LDM), and multiphase jet solidification (MJS)], photopolymerization [stereolithography (SLA), continuous liquid interface production (CLIP), and two-photon polymerization (2PP)], laser beam melting [selective laser sintering (SLS), selective laser melting (SLM), and direct metal laser sintering (DMLS)], electronic beam melting (EBM), laminated object manufacturing, and others.
- The market has been divided based on the application into external wearable devices (hearing aids, prosthesis and orthotics, and dental products), clinical study devices (drug testing and anatomical models), implants (surgical guides, cranio-maxillofacial implants, and orthopedic implants), and tissue engineering.
- Based on the end user, the market has been classified into medical and surgical centers, pharmaceutical and biotechnology companies, and academic institutions.
- Region-wise, the market has been segmented into North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa.
- The competitive landscape of the market has also been analyzed, with some of the key players being 3D Systems Inc., Desktop Metal Inc., EOS GmbH, Formlabs, Materialise NV, Organovo Holding Inc., Oxford Performance Materials Inc., Prodways Tech, Proto Labs Inc., Renishaw plc, SLM Solutions Group AG, and Stratasys Ltd.
|Base Year of the Analysis
||Material, Technology, Application, End User, Region
|| Asia Pacific, Europe, North America, Latin America, Middle East and Africa
||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
||3D Systems Inc., Desktop Metal Inc., EOS GmbH, Formlabs, Materialise NV, Organovo Holding Inc., Oxford Performance Materials Inc., Prodways Tech, Proto Labs Inc., Renishaw plc, SLM Solutions Group AG and Stratasys Ltd.
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N A
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800